Brazil study suggests AstraZeneca vaccine is effective against Brazil COVID-19 variant

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.

RIO DE JANEIRO, BRAZIL - Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil’s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday, March 8th.

The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.

  . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?